According to TipRanks.com, Baxter is a 1-star analyst with an average return of -2.7% and a 52.4% success rate. Baxter covers the Healthcare sector, focusing on stocks such as Molina Healthcare, Universal Health, and Community Health.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for HCA Healthcare with a $263.29 average price target, representing a 26.3% upside. In a report issued on April 22, Barclays also maintained a Hold rating on the stock with a $256.00 price target.
The company has a one-year high of $279.02 and a one-year low of $196.22. Currently, HCA Healthcare has an average volume of 1.64M.
Based on the recent corporate insider activity of 97 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of HCA in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Founded in 1968, HCA Healthcare, Inc. is a healthcare services company, based in Tennessee. The company operates general and psychiatric hospitals, freestanding surgery centers and emergency rooms, and urgent care centers. It also offers a full range of services to accommodate medical specialties such as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services.
Read More on HCA:
- Laboratory (LH) Received its Third Buy in a Row
- Wells Fargo Thinks Charles River Labs’ Stock is Going to Recover
- Analysts Offer Insights on Technology Companies: Check Point (CHKP), Identiv (INVE) and Elastic (ESTC)
- Analysts Offer Insights on Financial Companies: Digital Realty (DLR), WR Berkley (WRB) and Banner (BANR)
- Visa vs. Mastercard: Which Payment Processor Will Reap Rich Rewards?